Investigational antifungal agents

被引：40

作者：

Ernst, EJ ^{[1
]}

机构：

[1] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA

来源：

PHARMACOTHERAPY | 2001年 / 21卷 / 08期

关键词：

D O I：

10.1592/phco.21.12.165S.34509

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Several new antifungal agents, including novel compounds in familiar classes and entirely new classes targeting previously untapped mechanisms, are in various stages of the drug development process. Many new triazole antifungal agents are being studied, including voriconazole, posaconazole, and ravuconazole. The echinocandin antifungals, which represent a new class of antifungal agents, possess activity against a variety of fungal pathogens. The sodarin derivatives and nikkomycins are two additional classes of antifungals in early stages of development; future studies will determine their therapeutic usefulness.

引用

收藏

页码：165S / 174S

页数：10

相关论文

共 57 条

[1] In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872) [J].

Bartizal, K ;

Gill, CJ ;

Abruzzo, GK ;

Flattery, AM ;

Kong, L ;

Scott, PM ;

Smith, JG ;

Leighton, CE ;

Bouffard, A ;

Dropinski, JF ;

Balkovec, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) :2326-2332

[2]

BROWN GL, 2000, INT C ANT AG CHEM TO

[3] In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida [J].

Cacciapuoti, A ;

Loebenberg, D ;

Corcoran, E ;

Menzel, F ;

Moss, EL ;

Norris, C ;

Michalski, M ;

Raynor, K ;

Halpern, J ;

Mendrick, C ;

Arnold, B ;

Antonacci, B ;

Parmegiani, R ;

Yarosh-Tomaine, T ;

Miller, GH ;

Hare, RS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (08) :2017-2022

[4]

CATANZARO A, 2000, INT C ANT AG CHEM TO

[5] In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients [J].

Chávez, M ;

Bernal, S ;

Valverde, A ;

Gutierrez, MJ ;

Quindós, G ;

Mazuelos, EM .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (05) :697-700

[6] Efficacy of nikkomycin Z against experimental pulmonary blastomycosis [J].

Clemons, KV ;

Stevens, DA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) :2026-2028

[7] ANTIBIOTICS THAT INHIBIT FUNGAL CELL-WALL DEVELOPMENT [J].

DEBONO, M ;

GORDEE, RS .

ANNUAL REVIEW OF MICROBIOLOGY, 1994, 48 :471-497

[8] In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds [J].

DelPoeta, M ;

Schell, WA ;

Perfect, JR .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (08) :1835-1836

[9] In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY antimicrobial surveillance program in North America and Latin America [J].

Diekema, DJ ;

Pfaller, MA ;

Messer, SA ;

Houston, A ;

Hollis, RJ ;

Doern, GV ;

Jones, RN .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (09) :2236-2239

[10] Identification of elongation factor 2 as the essential protein targeted by sordarins in Candida albicans [J].

Domínguez, JM ;

Martín, JJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) :2279-2283

← 1 2 3 4 5 6 →